Malignant Pelvic Neoplasm — Trials

Malignant Pelvic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

48 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 5
Ph III recruiting: 1
Growth YoY: —
Industry share: 44%
Top sponsor: Baptist Health South Florida
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03111069	Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children	withdrawn	Phase 1	0	M.D. Anderson Cancer CenterOTHER	0	Jul 20, 2018	clinicaltrials

Data updated 23 days agoSource updated Jul 20, 2018source: clinicaltrials